University of California, Los Angeles — Los Angeles, California

Public research footprint of University of California, Los Angeles, compiled from the ClinicalTrials.gov public registry.

1,324

Registered studies

450

Active

257

Recruiting now

632

Completed

191

Stopped or withdrawn

Most-studied conditions

Amyotrophic Lateral Sclerosis · Resectable Pancreatic Ductal Adenocarcinoma (PDAC) · Early Parkinson Disease (Early PD) · Diffuse Large B-cell Lymphoma

Recently updated registry entries

NCT03767244 — A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced… (Active Not Recruiting)
NCT06873581 — Pivotal Study of Voro Urologic Scaffold (Active Not Recruiting)
NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of California, Los Angeles?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.